|487.74||+5.21||+1.08%||Vol 340.06K||1Y Perf 15.81%|
|Aug 9th, 2022 16:03 DELAYED|
|- -||- -%|
|Target Price||511.18||Analyst Rating||Strong Buy 1.53|
|Potential %||4.81||Finscreener Ranking||★★★ 49.93|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★ 50.95|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★+ 54.17|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||★+ 34.02|
|Price Range Ratio 52W %||93.35||Earnings Rating||Strong Buy|
|Market Cap||61.72B||Earnings Date||27th Jul 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||7.67|
|EPS Growth Next 5 Years %||14.10|
|Avg. Weekly Volume||551.48K|
|Avg. Monthly Volume||832.38K|
|Avg. Quarterly Volume||783.78K|
Humana Inc. (NYSE: HUM) stock closed at 487.74 per share at the end of the most recent trading day (a 1.08% change compared to the prior day closing price) with a volume of 340.06K shares and market capitalization of 61.72B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 48700 people. Humana Inc. CEO is Bruce D. Broussard.
The one-year performance of Humana Inc. stock is 15.81%, while year-to-date (YTD) performance is 5.15%. HUM stock has a five-year performance of 93.8%. Its 52-week range is between 351.2 and 497.47, which gives HUM stock a 52-week price range ratio of 93.35%
Humana Inc. currently has a PE ratio of 20.70, a price-to-book (PB) ratio of 4.03, a price-to-sale (PS) ratio of 0.93, a price to cashflow ratio of 18.50, a PEG ratio of 2.32, a ROA of 7.44%, a ROC of -% and a ROE of 21.14%. The company’s profit margin is 3.72%, its EBITDA margin is -%, and its revenue ttm is $65.72 Billion , which makes it $519.56 revenue per share.
Of the last four earnings reports from Humana Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $7.67 for the next earnings report. Humana Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Humana Inc. is Strong Buy (1.53), with a target price of $511.18, which is +4.81% compared to the current price. The earnings rating for Humana Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Humana Inc. has a dividend yield of 0.65% with a dividend per share of $3.15 and a payout ratio of 9.00%.
Humana Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 8.67, ATR14 : 10.07, CCI20 : 18.09, Chaikin Money Flow : 0.15, MACD : 4.04, Money Flow Index : 50.11, ROC : -0.65, RSI : 59.80, STOCH (14,3) : 52.88, STOCH RSI : 0.28, UO : 56.99, Williams %R : -47.12), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Humana Inc. in the last 12-months were: Bruce D. Broussard (Option Excercise at a value of $12 147 739), Bruce D. Broussard (Sold 50 006 shares of value $22 737 765 ), Cynthia H. Zipperle (Option Excercise at a value of $0), David A. Jones (Sold 4 800 shares of value $1 924 800 ), Heather M. Carroll Cox (Option Excercise at a value of $0), Jorge S. Mesquita (Option Excercise at a value of $0), Joseph C. Ventura (Option Excercise at a value of $0), Marcy S. Klevorn (Option Excercise at a value of $0), Raquel C. Bono (Option Excercise at a value of $0), Samir Deshpande (Option Excercise at a value of $0), Samir Deshpande (Sold 3 957 shares of value $1 718 100 ), Susan D. Schick (Option Excercise at a value of $0), Susan M. Diamond (Option Excercise at a value of $0), Timothy Alan Wheatley (Option Excercise at a value of $0), Timothy S. Huval (Option Excercise at a value of $0), Timothy S. Huval (Sold 3 477 shares of value $1 540 797 ), Vishal Agrawal (Option Excercise at a value of $0), William H Shrank (Option Excercise at a value of $0), William Kevin Fleming (Option Excercise at a value of $0), William Kevin Fleming (Sold 3 210 shares of value $1 443 470 )
Sat, 30 Jul 2022 01:50 GMT RBC Capital Believes Humana (HUM) Wont Stop Here- TipRanks. All rights reserved.
Thu, 28 Jul 2022 12:15 GMT Analysts Offer Insights on Healthcare Companies: Amedisys (AMED), Humana (HUM) and Teladoc (TDOC)- TipRanks. All rights reserved.
Sat, 30 Apr 2022 07:26 GMT Analysts Opinions Are Mixed on These Healthcare Stocks: Humana (HUM), Abiomed (ABMD) and Icon (ICLR)- TipRanks. All rights reserved.
Fri, 29 Apr 2022 04:07 GMT Mizuho Securities Believes Humana (HUM) Wont Stop Here- TipRanks. All rights reserved.
Thu, 28 Apr 2022 12:38 GMT Humana (HUM) Gets a Buy Rating from Leerink Partners- TipRanks. All rights reserved.
Wed, 23 Feb 2022 10:37 GMT Making Sense of Humanas Risk Factors- TipRanks. All rights reserved.
Fri, 04 Feb 2022 01:47 GMT Humana (HUM) Gets a Buy Rating from RBC Capital- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.